ArticleProstate international2017
Evaluation of the changing landscape of prostate cancer diagnosis and management from 2005 to 2016.
Article in Prostate international, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Germline DNA-Repair Genes and HOXB13 Mutations in Korean Men with Metastatic Prostate Cancer: Data from a Large Korean Cohort.The world journal of men's health · 2023Article
- Temporal changes of PIRADS scoring by radiologists and correlation to radical prostatectomy pathological outcomes.Prostate international · 2022Article
- Innovative standardized reporting template for prostate mpMRI improves clarity and confidence in the report.World journal of urology · 2021Article
- Adoption of immunotherapy in the community for patients diagnosed with metastatic melanoma.Journal for immunotherapy of cancer · 2019Article
- Is There an Optimal Curative Option in HIV-Positive Men with Localized Prostate Cancer? A Systematic Review.Current urology · 2019Review
- Quantitative characterisation of clinically significant intra-prostatic cancer by prostate-specific membrane antigen (PSMA) expression and cell density on PSMA-11.European radiology · 2018Article
- Review of Gallium-68 PSMA PET/CT Imaging in the Management of Prostate Cancer.Diagnostics (Basel, Switzerland) · 2018Review
- An unusual localization of seven months delayed pelvic lymphocele following radical retropubic prostatectomy: Case report and literature review.International journal of surgery case reports · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundApproaches to prostate cancer (PCa) diagnosis and treatment have evolved significantly over past decades. There has been an increasing focus on minimizing overdiagnosis and overtreatment of clinically insignificant PCa. The objective of this study was to evaluate the changes in the diagnostic approach and initial treatment strategy that has evolved over time in an Australian urological private practice. MATERIALS AND
methodsMen with newly diagnosed PCa were identified from the private practice electronic and paper medical records from 2005 to 2016 and data was consolidated into six groups of 2-year intervals. Diagnostic strategy was analyzed with particular reference to the use of multiparametric magnetic resonance imaging (mpMRI) scan and
resultsChart review identified 839 men who had a mean age of 65.8 years. In 2011-2012, prebiopsy mpMRI scan was introduced. Its uptake correlated with a decrease in numbers of men diagnosed with low risk cancer (r = -0.80,
conclusionPrebiopsy mpMRI has been associated with an increased proportion of newly diagnosed men having clinically significant PCa. Over time,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.